At Diagnopein Diagnostic Centre, Nashik, we provide accurate and reliable DCP/PIVKA-II (serum) testing using advanced immunoassa
The DES-GAMMA-CARBOXY-PROTHROMBIN (DCP) test, also known as PIVKA-II (Protein Induced by Vitamin K Absence or Antagonist-II), is a specialized liver cancer marker test that measures abnormal prothrombin levels in the blood. This diagnostic test plays an essential role in identifying and monitoring hepatocellular carcinoma (HCC), which is the most common type of primary liver cancer.
The DCP test (DES-GAMMA-CARBOXY-PROTHROMBIN) is clinically important for patients undergoing evaluation for hepatocellular carcinoma or other liver disorders. Normally, the liver produces prothrombin with the help of vitamin K. However, when there is liver damage or malignancy, an abnormal form called PIVKA-II appears in the bloodstream. Measuring this protein helps physicians assess liver function and cancer risk.
In patients with chronic hepatitis B, chronic hepatitis C, or liver cirrhosis, regular testing for DCP / PIVKA-II markers can help identify cancerous changes at an early stage, before severe symptoms emerge. Using both Alpha-Fetoprotein (AFP) and PIVKA-II (serum) levels together drastically improves accuracy in liver cancer screening.
Diagnopein Diagnostic Centre in Nashik emphasizes preventive health and early detection. Our liver tumor marker test panels, including DCP / PIVKA-II, are trusted by physicians across the region. This test aids in confirming diagnosis, guiding treatment choices, and monitoring post-surgical or post-therapy recovery.
Opting for DCP/PIVKA-II testing at Diagnopein Nashik offers several diagnostic and clinical benefits:
Early liver cancer detection: Detects hepatocellular carcinoma early, even before imaging shows visible lesions.
Improved diagnostic accuracy: When combined with AFP and imaging, provides a clear picture of liver health.
Efficient treatment monitoring: Assesses therapy response and helps predict recurrence after liver surgery or ablation.
Non-invasive procedure: Requires a simple blood sample, making it convenient for patients.
State-of-the-art technology: Performed using modern immunoassay platforms for reliable quantification.
Trusted diagnostics in Nashik: Diagnopein is a well-established name known for accuracy, speed, and professionalism.
Our team at Diagnopein Diagnostic Centre in Nashik ensures every liver test, including DCP / PIVKA-II, Liver Function Tests (LFTs), and AFP tumor markers, meets stringent quality standards. Every report is reviewed by certified pathologists for complete reliability.
At Diagnopein Nashik, the DES-GAMMA-CARBOXY-PROTHROMBIN (DCP) / PIVKA-II (serum) test is performed using standardized laboratory techniques.
Sample collection: A blood sample is collected from a vein, usually without the need for fasting.
Laboratory analysis: The serum portion is separated and tested using an automated immunoassay analyzer.
Result measurement:
Normal DCP level: Generally below 40 ng/mL (values vary based on lab reference).
Elevated DCP/PIVKA-II levels: Often indicate possible hepatocellular carcinoma (HCC) or severe liver disease.
Medical interpretation: Always reviewed by a physician who may suggest additional imaging like ultrasound, CT, or MRI for confirmation.
Patients at Diagnopein Nashik receive detailed reports and counseling support to understand results and follow next diagnostic steps if needed.
This test is recommended in the following situations:
Chronic hepatitis B or C infections.
Diagnosed or suspected liver cirrhosis.
History of liver cancer treatment or hepatic surgery.
Family history of liver malignancy.
Regular cancer monitoring or surveillance programs.
Doctors may recommend a combined AFP and PIVKA-II test for high-risk individuals to achieve accurate early detection.
Diagnopein Diagnostic Centre in Nashik is a trusted healthcare brand known for delivering accurate, consistent, and advanced pathology results. Our center combines the latest testing systems with skilled laboratory professionals to ensure dependable reporting.
Patients prefer Diagnopein Nashik for:
NABL-accredited laboratory standards.
Advanced ultrasonic and biochemical analyzers.
Customer-focused staff and hygienic collection methods.
Online test booking and report access.
Experienced consultants for medical test interpretation.
Our mission is to empower community health by providing affordable, precise, and early liver cancer screening and diagnostic services including the DCP / PIVKA-II test, AFP test, and complete liver function evaluation.
At Diagnopein Nashik, we care about early cancer detection and preventive diagnostics. The DES-GAMMA-CARBOXY-PROTHROMBIN test, or PIVKA-II, is a reliable path toward protecting liver health—helping detect disease before it advances.
No special preparation is typically required before the DCP/PIVKA II test. However, follow any specific instructions given by your healthcare provider.
The DCP test is low-risk, as it involves a standard blood draw. The main risks include slight pain, bruising, or infection at the needle site.
The test is primarily used to help diagnose hepatocellular carcinoma, monitor liver disease progression, differentiate between HCC and other liver conditions, and assess treatment response in patients with liver cancer.
Certain medications may influence liver function and, consequently, DCP levels. It’s important to inform your healthcare provider about all medications you are taking.
